Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Even Non-Compatible Implanted Devices Are Safe for MRI Scans

By HospiMedica International staff writers
Posted on 02 Nov 2020
A new study confirms that magnetic resonance imaging (MRI) scans can be safely performed in patients using appropriate safety protocols, including those who have non-MR compatible implanted devices.

The study, conducted by researchers at Saint Luke's Mid America Heart Institute (Kansas City, MO, USA) and other institutions, involved a total of 532 participants (211 women, mean age 69 years), who underwent 608 MRI examinations. More...
All participants had device interrogations performed before and after each MRI. During the scan, pacemaker-dependent patients received asynchronous pacing, and patients with an implantable cardioverter defibrillator (ICD) had tachycardia therapies disabled. An electrophysiology nurse monitored patients for hemodynamic or rhythm abnormalities.

Clinical utility surveys of the MRI examinations were completed by 150 physicians, and according to the survey responses, the examinations changed the suspected diagnosis 25% of the time, and changed suspected prognosis in 26% of participants, with planned medical or surgical treatment being changed 42% of the time. Cardiac devices comprised 27% of all MRI examinations, and included pacemakers (46%), ICDs (30%), cardiac resynchronization therapy (CRT) pacemakers (4%), CRT defibrillators (17%), and abandoned leads (2%). The study was published on October 22, 2020, in Radiology: Cardiothoracic Imaging.

“While all devices implanted in patients today are MRI compatible, millions of people worldwide, including many young people, have older devices considered not compatible. It’s unfair to tell these people that they can’t get an MRI for the rest of their lives,” said lead author cardiologist Sanjaya Gupta, MD. “We found no serious adverse consequences of performing MRI examinations, including cardiac MRI examinations. The protocol worked amazingly well; we had no issues with any of the patients and no harm to the devices.”

Until now, patients with non-MR compatible devices have been contraindicated from receiving MRI scans because of potential interactions between the MRI and device function, which might result in risk to patients. The restriction has resulted in a critical unmet need, as data have shown that about 36% of such patients in the United States alone are likely to need an MRI.

Related Links:
Saint Luke's Mid America Heart Institute


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Gold Member
Electrode Solution and Skin Prep
Signaspray
Morcellator
TCM 3000 BL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.